Basis: Four-quarter free cash flow / FMP quote market capitalization × 100. Source: stored company filings and market data; unavailable inputs remain N/A.
The free cash flow yield is N/A as of 2026-10-06T16:17:29.721Z.
Calculation as of: 2026-10-06T16:17:29.721Z.
Quote observation: 2026-10-06T16:15:20.000Z. Amounts in USD. The price header may show a later quote.
FMP input reference: e0aae41c25609cbe98cd8c59fbdc20e812e1ea61d6a67e0b8df2c56749153647
Historical values estimate market capitalization from statement-period weighted shares. Comparisons with the current quote-based value are approximate. Only filing versions delivered by FMP are available for the historical calculation.
FREE CASH FLOW YIELD
N/A
Kyverna Therapeutics, Inc.
Market Cap
$384.40M
Free Cash Flow Yield
N/A
TTM Avg
N/A
3Y Avg
N/A
5Y Avg
N/A
Market Cap
$386.23M
Free Cash Flow Yield
N/A
TTM Avg
0.08%
3Y Avg
0.08%
5Y Avg
3.89%
Market Cap
$378.17M
Free Cash Flow Yield
N/A
TTM Avg
13.37%
3Y Avg
10.70%
5Y Avg
10.70%
Market Cap
$393.42M
Free Cash Flow Yield
N/A
TTM Avg
11.28%
3Y Avg
11.28%
5Y Avg
6.55%
Market Cap
$393.86M
Free Cash Flow Yield
N/A
TTM Avg
N/A
3Y Avg
N/A
5Y Avg
N/A
Market Cap
$373.86M
Free Cash Flow Yield
N/A
TTM Avg
N/A
3Y Avg
N/A
5Y Avg
N/A
Market Cap
$408.96M
Free Cash Flow Yield
N/A
TTM Avg
N/A
3Y Avg
N/A
5Y Avg
N/A
| NAME | MARKET CAP | FREE CASH FLOW YIELD | TTM | 3Y | 5Y |
|---|---|---|---|---|---|
| Kyverna Therapeutics, Inc. (KYTX) | $384.40M | N/A | N/A | N/A | N/A |
| Orthofix Medical Inc. (OFIX)vs › | $386.23M | N/A | 0.08% | 0.08% | 3.89% |
| Arcturus Therapeutics Holdings Inc. (ARCT)vs › | $378.17M | N/A | 13.37% | 10.70% | 10.70% |
| REGENXBIO Inc. (RGNX)vs › | $393.42M | N/A | 11.28% | 11.28% | 6.55% |
| MapLight Therapeutics, Inc. (MPLT)vs › | $393.86M | N/A | N/A | N/A | N/A |
| Canopy Growth Corporation (CGC)vs › | $373.86M | N/A | N/A | N/A | N/A |
| Opus Genetics, Inc. (IRD)vs › | $364.53M | N/A | N/A | N/A | N/A |
| Carlsmed, Inc. (CARL)vs › | $408.59M | N/A | N/A | N/A | N/A |
| Shoulder Innovations, Inc. (SI)vs › | $408.96M | N/A | N/A | N/A | N/A |
| Ocugen, Inc. (OCGN)vs › | $359.46M | N/A | N/A | N/A | N/A |
FCF Yield
N/A
Earnings Yield
N/A
Dividend Yield
N/A
Formula: FCF Yield = (Free Cash Flow / Market Cap) × 100
How FCF Yield is used:
FCF vs earnings: Differences between FCF yield and earnings yield can reflect capital expenditures, working capital changes, and other non-cash accounting items.
FCF Yield measures free cash flow relative to market capitalization. It compares cash generation after capital expenditures with the equity value of the company.
Expanded definitions: Investopedia, Wikipedia, Corporate Finance Institute
